Schedule 13G ownership disclosure

N/A

Security class unavailable · CUSIP: 78667J108

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,283,629
Percent of class
8.2300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000173
Form type
SC 13G
Filer
Sage Therapeutics, Inc.
CIK
CIK 1597553
Filed
Feb 04, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub